Portfolio company
Zafrens
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a high-throughput single-cell analysis platform for pharmaceutical and biotechnology researchers to conduct simultaneous phenotypic and molecular drug discovery screenings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Abiosciences
This company provides single-cell genomics and bioinformatics platforms to pharmaceutical companies and researchers for drug target and biomarker discovery.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Atrandi Biosciences
This company develops single-cell analysis platforms and microfluidic technologies for life science researchers in genomics, screening and biological innovation.
Cytomos
Cytomos develops label-free cell analysis platforms for biopharmaceutical companies to accelerate drug discovery and streamline manufacturing processes.
